Search Results 541-550 of 17305 for Conduction

1. Using photon-counting CT to guide treatment for conductive hearing loss - Mayo Clinic

   Photon-counting CT delivers high-resolution imaging that enhances evaluation of middle ear structures. This advanced modality supports more-accurate ...

2. Ablation therapy - Doctors & Departments - Mayo Clinic

   ... Conduction system disease. Show more areas of focus for Anca Chiriac, M.D., Ph.D. Ryan S. D'Souza, M.D.. Anesthesiologist. Rochester, MN ...

3. A Study to Evaluate Inflammation of the Heart Muscle Tissue in Patients with Rheumatoid Arthritis - Mayo Clinic

   Irregular heart rhythm (arrhythmia or cardiac conduction abnormality (i.e., atrial fibrillation or flutter, frequentextrasystole, LBBB). Relevant valvular ...

4. Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma - Mayo Clinic

   Conduction abnormality requiring a pacemaker; Symptomatic pericarditis; Myocardial infraction within the last 6 months, documented by persistent elevated ...

5. Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Severe uncontrolled ventricular arrhythmias or electrocardiographic evidence of active conduction system abnormalities; Cardiac amyloidosis with hypotension ...

6. Mayo Clinic Researchers Investigate Innovations in Heart Transplant

   Langendorff systems have been used to test the effects of drugs on the heart, electrical conduction, the effect of genetic mutations, and myriad of other ...

7. 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease - Mayo Clinic

   History of unstable angina, myocardial infarction, advanced chronic heart failure, or clinically significant conduction abnormalities within 1 year prior to ...

8. A Study of SC-006 in Subjects With Advanced Cancer - Mayo Clinic

   Has a history of cardiac conduction abnormalities including: QTcF >470 msec;; ECG with second degree type 2 or third degree atrioventricular block, and left ...

9. A Study to Evaluate the Effectiveness and Safety of Ralinepag To Improve Treatment Outcomes in Peripheral Arterial Hypertension (PAH) Patients - Mayo Clinic

   ... conduction delay (IVCD). In presence of IVCD, subjects will be excluded if QTcF. > 500 msec for both males and females. Severe chronic liver disease (ie ...

10. VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM - Mayo Clinic

    No clinically significant cardiac conduction disorder on screening. Female patients of child-bearing potential must have a negative serum or urine pregnancy ...